Determinants of Achieved LDL Cholesterol and “Non-HDL” Cholesterol in the Management of Dyslipidemias-Reference-Cited by-同舟云学术

Determinants of Achieved LDL Cholesterol and “Non-HDL” Cholesterol in the Management of Dyslipidemias

Published:2018-06-14 Issue:8 Volume:20 Page:
ISSN:1523-3782
Container-title:Current Cardiology Reports
language:en
Short-container-title:Curr Cardiol Rep

Author:

Packard Chris J.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1007/s11886-018-1003-x/fulltext.html

Reference67 articles.

1. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1–45.

2. Piepoli MF, Hoes AW, Agewall S, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2016;23:Np1-np96.

3. •• Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–72. A seminal overview that brings together evidence from multiple fields of investigation to support the causal role of LDL in atherogenesis. This is a very useful resource to counteract the claims of those who question the benefits of focusing on lipoproteins as targets for therapy.

4. • Varbo A, Nordestgaard BG. Remnant lipoproteins. Curr Opin Lipidol. 2017;28:300–7. An insightful review of methods of measuring remnant lipoproteins and their association with risk of CHD .

5. • Vitali C, Khetarpal SA, Rader DJ. HDL cholesterol metabolism and the risk of CHD: new insights from human genetics. Curr Cardiol Rep. 2017;19:132. This article offers an excellent overview of where we are in understanding HDL and its relationship to cardiovascular disease.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the association between testosterone and cardiovascular disease potential risk factor apolipoprotein B in adult males without cancer: national health and nutrition examination survey 2011-2016;Frontiers in Endocrinology;2024-02-16

2. Association of apolipoprotein B with all-cause and cardiovascular mortality among adults: Results from the National Health and Nutrition Examination Surveys;The American Journal of the Medical Sciences;2023-11

3. Analysis of the association between serum antiaging humoral factor klotho and cardiovascular disease potential risk factor apolipoprotein B in general population;Medicine;2023-06-23

4. Integrating Advanced Lipid Testing and Biomarkers in Assessment and Treatment;Current Cardiology Reports;2022-08-24

5. Variable Expressivity in Type 2 Familial Partial Lipodystrophy Related to R482 and N466 Variants in the LMNA Gene;Journal of Clinical Medicine;2021-03-18